Table 2.

The relationship between bone mineral density (BMD) and other characteristics via linear regression models, using BMD as the dependent variable, which is adjusted for age, sex, and ferritin. Regression coefficients (coef.) and P-values are shown (n = 27).

BMD of lumbar spine, Z score (SD)BMD of femoral neck, Z score (SD)
coef.Pcoef.P
Age (year)–0.022.757–0.053.266
Gender0.226.7760.002.997
Body height (cm)–0.008.8830.083.089
Body mass index (kg/m2)–0.085.5620.116.252
Difference of real height from expected height (cm)–0.005.9090.081.070
Fracturea–0.309.696–0.889.162
Calciumb (mmol/L)1.309.8102.279.569
Phosphorus (mg/dL)0.070.9060.202.613
25(OH)D (ng/mL)0.074.247–0.111.283
25(OH)D deficiencyc–1.984.260N/AdN/Ad
iPTH (pg/mL)–0.017.264–0.028.016
FGF23 (pg/mL)–0.014.118–0.016.025
FGF23 statuse–1.682.025–0.921.166
Hypothyroidismf–1.053.024–1.070.004
fT4 (ng/dL)3.358.2191.758.367
TSH (μU/mL)–0.323.284–0.408.043
Hypogonadismg–0.649.416–0.639.318
Estradiol in female (pg/mL)0.053.1640.011.470
Testosterone in male (ng/mL)0.440.0110.173.490
IGF-1 (ng/mL)0.041.028–0.003.818
Growth hormone deficiencyh–0.944.3860.498.480
DMi–0.461.581–0.096.868
HbA1C (%)–0.747.042–0.344.276
Hb (g/dL)0.274.302–0.016.943
ACTH (pg/mL)0.074.0240.054.034
Cortisol (μg/dL)0.045.644–0.045.572
Ferritin (ng/mL)0.0002.436–0.0001.193
BMD of lumbar spine, Z score (SD)BMD of femoral neck, Z score (SD)
coef.Pcoef.P
Age (year)–0.022.757–0.053.266
Gender0.226.7760.002.997
Body height (cm)–0.008.8830.083.089
Body mass index (kg/m2)–0.085.5620.116.252
Difference of real height from expected height (cm)–0.005.9090.081.070
Fracturea–0.309.696–0.889.162
Calciumb (mmol/L)1.309.8102.279.569
Phosphorus (mg/dL)0.070.9060.202.613
25(OH)D (ng/mL)0.074.247–0.111.283
25(OH)D deficiencyc–1.984.260N/AdN/Ad
iPTH (pg/mL)–0.017.264–0.028.016
FGF23 (pg/mL)–0.014.118–0.016.025
FGF23 statuse–1.682.025–0.921.166
Hypothyroidismf–1.053.024–1.070.004
fT4 (ng/dL)3.358.2191.758.367
TSH (μU/mL)–0.323.284–0.408.043
Hypogonadismg–0.649.416–0.639.318
Estradiol in female (pg/mL)0.053.1640.011.470
Testosterone in male (ng/mL)0.440.0110.173.490
IGF-1 (ng/mL)0.041.028–0.003.818
Growth hormone deficiencyh–0.944.3860.498.480
DMi–0.461.581–0.096.868
HbA1C (%)–0.747.042–0.344.276
Hb (g/dL)0.274.302–0.016.943
ACTH (pg/mL)0.074.0240.054.034
Cortisol (μg/dL)0.045.644–0.045.572
Ferritin (ng/mL)0.0002.436–0.0001.193

25(OH)D, 25-hydroxyvitamin D; ACTH, adrenocorticotropin; DM, diabetes mellitus; FGF23, fibroblast growth factor 23; fT4, free thyroxine; iPTH, intact parathyroid hormone; N/A: not available; TSH, thyroid stimulating hormone.

aFracture: 0, no fracture; 1, fracture.

bCalcium was corrected by: calcium (mmol/L) + 0.2 × (albumin (g/dL) – 4).

c25(OH)D ≤ 24 ng/mL was defined as deficiency (1). 25(OH)D higher than 24 ng/mL was defined as normal (0).

dN/A, not available. This is because all of the 20 patients who had 25(OH)D and BMD of the femoral neck checked had 25(OH)D deficiency.

eFGF23 status: FGF23 < 8.2 pg/mL was defined as low (–1), FGF23 between 8.2 and 54.3 pg/mL was defined as normal (0), and FGF23 > 54.3 pg/mL was defined as high (1).

fHypothyroidism: 0, euthyroid; 1, subclinical hypothyroidism; 2, hypothyroidism.

gHypogonadism: 0, normal gonad function; 1, hypogonadism.

hGrowth hormone deficiency: 0, normal; 1, deficiency.

iDM: 0, euglycemia; 1, pre-DM; 2: DM.

Table 2.

The relationship between bone mineral density (BMD) and other characteristics via linear regression models, using BMD as the dependent variable, which is adjusted for age, sex, and ferritin. Regression coefficients (coef.) and P-values are shown (n = 27).

BMD of lumbar spine, Z score (SD)BMD of femoral neck, Z score (SD)
coef.Pcoef.P
Age (year)–0.022.757–0.053.266
Gender0.226.7760.002.997
Body height (cm)–0.008.8830.083.089
Body mass index (kg/m2)–0.085.5620.116.252
Difference of real height from expected height (cm)–0.005.9090.081.070
Fracturea–0.309.696–0.889.162
Calciumb (mmol/L)1.309.8102.279.569
Phosphorus (mg/dL)0.070.9060.202.613
25(OH)D (ng/mL)0.074.247–0.111.283
25(OH)D deficiencyc–1.984.260N/AdN/Ad
iPTH (pg/mL)–0.017.264–0.028.016
FGF23 (pg/mL)–0.014.118–0.016.025
FGF23 statuse–1.682.025–0.921.166
Hypothyroidismf–1.053.024–1.070.004
fT4 (ng/dL)3.358.2191.758.367
TSH (μU/mL)–0.323.284–0.408.043
Hypogonadismg–0.649.416–0.639.318
Estradiol in female (pg/mL)0.053.1640.011.470
Testosterone in male (ng/mL)0.440.0110.173.490
IGF-1 (ng/mL)0.041.028–0.003.818
Growth hormone deficiencyh–0.944.3860.498.480
DMi–0.461.581–0.096.868
HbA1C (%)–0.747.042–0.344.276
Hb (g/dL)0.274.302–0.016.943
ACTH (pg/mL)0.074.0240.054.034
Cortisol (μg/dL)0.045.644–0.045.572
Ferritin (ng/mL)0.0002.436–0.0001.193
BMD of lumbar spine, Z score (SD)BMD of femoral neck, Z score (SD)
coef.Pcoef.P
Age (year)–0.022.757–0.053.266
Gender0.226.7760.002.997
Body height (cm)–0.008.8830.083.089
Body mass index (kg/m2)–0.085.5620.116.252
Difference of real height from expected height (cm)–0.005.9090.081.070
Fracturea–0.309.696–0.889.162
Calciumb (mmol/L)1.309.8102.279.569
Phosphorus (mg/dL)0.070.9060.202.613
25(OH)D (ng/mL)0.074.247–0.111.283
25(OH)D deficiencyc–1.984.260N/AdN/Ad
iPTH (pg/mL)–0.017.264–0.028.016
FGF23 (pg/mL)–0.014.118–0.016.025
FGF23 statuse–1.682.025–0.921.166
Hypothyroidismf–1.053.024–1.070.004
fT4 (ng/dL)3.358.2191.758.367
TSH (μU/mL)–0.323.284–0.408.043
Hypogonadismg–0.649.416–0.639.318
Estradiol in female (pg/mL)0.053.1640.011.470
Testosterone in male (ng/mL)0.440.0110.173.490
IGF-1 (ng/mL)0.041.028–0.003.818
Growth hormone deficiencyh–0.944.3860.498.480
DMi–0.461.581–0.096.868
HbA1C (%)–0.747.042–0.344.276
Hb (g/dL)0.274.302–0.016.943
ACTH (pg/mL)0.074.0240.054.034
Cortisol (μg/dL)0.045.644–0.045.572
Ferritin (ng/mL)0.0002.436–0.0001.193

25(OH)D, 25-hydroxyvitamin D; ACTH, adrenocorticotropin; DM, diabetes mellitus; FGF23, fibroblast growth factor 23; fT4, free thyroxine; iPTH, intact parathyroid hormone; N/A: not available; TSH, thyroid stimulating hormone.

aFracture: 0, no fracture; 1, fracture.

bCalcium was corrected by: calcium (mmol/L) + 0.2 × (albumin (g/dL) – 4).

c25(OH)D ≤ 24 ng/mL was defined as deficiency (1). 25(OH)D higher than 24 ng/mL was defined as normal (0).

dN/A, not available. This is because all of the 20 patients who had 25(OH)D and BMD of the femoral neck checked had 25(OH)D deficiency.

eFGF23 status: FGF23 < 8.2 pg/mL was defined as low (–1), FGF23 between 8.2 and 54.3 pg/mL was defined as normal (0), and FGF23 > 54.3 pg/mL was defined as high (1).

fHypothyroidism: 0, euthyroid; 1, subclinical hypothyroidism; 2, hypothyroidism.

gHypogonadism: 0, normal gonad function; 1, hypogonadism.

hGrowth hormone deficiency: 0, normal; 1, deficiency.

iDM: 0, euglycemia; 1, pre-DM; 2: DM.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close